RCM
ZBH icon

Raleigh Capital Management’s Zimmer Biomet ZBH Stock Holding History

Raleigh Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– – – 760
2025
Q4 		– Hold
0
– – – 568
2025
Q3 		– Hold
0
– – – 530
2025
Q2 		– Hold
0
– – – 630
2025
Q1 		– Sell
-73
Closed -$7.81K – 560
2024
Q4 		$7.72K Buy
73
+25
+52% +$2.68K ﹤0.01% 645
2024
Q3 		$5.19K Sell
48
-60
-56% -$6.55K ﹤0.01% 694
2024
Q2 		$11.7K Buy
108
+29
+37% +$3.42K 0.01% 544
2024
Q1 		$10.4K Sell
79
-140
-64% -$17.5K ﹤0.01% 554
2023
Q4 		$26.7K Buy
219
+26
+13% +$2.9K 0.01% 386
2023
Q3 		$21.7K Buy
193
+55
+40% +$6.99K 0.01% 382
2023
Q2 		$20.1K Buy
138
+95
+221% +$12.9K 0.01% 392
2023
Q1 		$5.56K Buy
+43
New +$5.4K ﹤0.01% 596

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raleigh Capital Management's ZBH Position: Q1 2026 in Review

Raleigh Capital Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 0 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #760.

Raleigh Capital Management first reported a position in ZBH in Q1 2023 and has held it in 8 quarters since. The position peaked at $26.7K in Q4 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Raleigh Capital Management held 0 shares of Zimmer Biomet worth $6 as of Q1 2026.
  • Raleigh Capital Management left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Raleigh Capital Management's portfolio in Q1 2026, its #760 holding.
  • Raleigh Capital Management first reported a position in Zimmer Biomet in Q1 2023 and has held it in 8 quarters since.
  • Raleigh Capital Management's Zimmer Biomet position peaked at $26.7K in Q4 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Raleigh Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.